BayOConnect 2026 on 30 June - 1 July 2026 in Munich highlights what truly drives growth in biotechnology: Europe as a competitive innovation hub, capital turning innovation into scale, and breakthrough technologies shaping biotech and beyond.
Here’s a first glimpse at three selected sessions from our upcoming program:
Innovation cleared for Market: From Innovation to Impact: How do we ensure our ecosystem is ready for game-changers in biotech innovation?
From clinical development to regulatory approval, navigating regulatory landscape efficiently is key to translating scientific breakthroughs into approved, patient‑ready solutions across Europe. Let’s hear directly from Dr. Ulrich Granzer (Granzer Regulatory Consulting & Service), Dr. Thomas Sudhop (BfARM) and representative of MSD on practical insights and proven success factors.
Beyond Biotech: Enabling Technologies for Tomorrow’s Health
From Data Sharing & Data Protection in Cloud Services with Dr. Max Tschohohei (Google Cloud EMEA) and the AI Accubator with Prof. Thomas Brück (Werner Siemens-Chair ofSynthetic Biotechnology, TUM) to Software as a Medical Device presented by Prof. Ludwig Christian Hinske (Institute of Digital Medicine, University Hospital Augsburg), this session highlights the core digital enablers of next‑generation healthcare. Molecular Computing with Prof. Philipp Tinnefeld (Department of Chemistry, LMU), as well as BigTech and MedTech perspectives (tbc) complete the picture from infrastructure to application.
R&D Outlook from Leading Pharma Innovators
Strategic insights into research priorities, partnership models and innovation strategies from global pharmaceutical leaders - chaired by Dr. Simon Moroney (Board Member & Vice‑Chair, Novartis), this session brings together strategic R&D perspectives from Dr. Matthias Meergans (Managing Director R&D, vfa), Dr. Kai Joachimsen (CEO, BPI), Dr. Susanne Kreuz (Global Head of Corporate & Business Development, Novartis) and Dr. Jörg Radtke (Head of Servier Research Germany).
BayOConnect 2026: A Platform For Europe’s Future
With its 2026 program, BayOConnect reinforces Europe as a dynamic and forward-looking innovation ecosystem and strengthens Bavaria’s position within it. BayOConnect 2026 offers a unique opportunity to connect with key decision-makers, explore strategic partnerships and actively shape the future of biotech in Europe.
Stay tuned: www.bayoconnect.org
The ticket shop will open before the Easter!